In glioma cells, IGFBP2’s interaction with integrin alpha 5 is essential for cell mobility18, and the IGFBP2/integrin/ILK/NF-κB signaling pathway drives cancer progression in vivo34. Here, IGFBP2 is linked to central nervous system cancer.